Back to Search
SCOTT KAPLAN, PH.D.
PH.D.
Clinical Psychologist
NPI: 1174822019Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
071008091(IL)1915(KS)
Research & Publications (20)
PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer.
PMID 19328538·Urology·2009
2-rct
Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms.
PMID 19302502·BJU Int·2009
4-observational
The role of MR imaging in detecting nodal disease in thyroidectomy patients with rising thyroglobulin levels.
PMID 19039052·AJNR Am J Neuroradiol·2009
8-other
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
PMID 18510659·BJU Int·2008
4-observational
Antiretroviral therapy in HIV-infected patients with multidrug-resistant virus: applying the guidelines to practice.
PMID 19072099·AIDS Patient Care STDS·2008
6-review
Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.
PMID 18639298·J Urol·2008
2-rct
Commentary: Prevention of recurrent staphylococcal infections.
PMID 18756179·Pediatr Infect Dis J·2008
8-other
Introduction: BPH and sexual dysfunction--recommendations for the primary care physician and urologist.
PMID 19002118·Int J Impot Res·2008
8-other
Urinary retention and post-void residual urine in men: separating truth from tradition.
PMID 18485378·J Urol·2008
6-review
Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.
PMID 19032603·BJU Int·2008
6-review
Impact of BAC limit reduction on different population segments: a Poisson fixed effect analysis.
PMID 17920837·Accid Anal Prev·2007
8-other
Duration of therapy with metoclopramide: a prescription claims data study.
PMID 17436356·Pharmacoepidemiol Drug Saf·2007
8-other
Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms.
PMID 17592540·Rev Urol·2007
8-other
Open to debate. The motion: PDE5 inhibitors will have a significant role in the treatment of BPH.
PMID 17728048·Eur Urol·2007
6-review
[The role of muscarinic receptor antagonists in the treatment of men with lower urinary tract symptoms secondary to BPH].
PMID 17645086·Actas Urol Esp·2007
6-review
Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
PMID 17258855·Eur Urol·2007
2-rct
Identification of the patient with enlarged prostate: diagnosis and guidelines for management.
PMID 17620137·Osteopath Med Prim Care·2007
8-other
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
PMID 17105794·JAMA·2006
4-observational
The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men?
PMID 16952672·J Urol·2006
4-observational
Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia.
PMID 16904446·Urology·2006
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 N MICHIGAN AVE STE 1820
CHICAGO, IL 60602 - Phone
- (312) 882-3344
Quick Facts
- NPI
- 1174822019
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile